Cutler Group LP Adamis Pharmaceuticals Corp Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 07, 2018	BUY	$2.25 - $4.8 $96,750 - $206,400	43,000 Added 2529.41%	44,700 $18,000
Q1 2018 May 11, 2018	BUY	$2.55 - $4.85 $1,784 - $3,394	700 Added 70.0%	1,700 $1,000
Q4 2017 Jan 17, 2018	SELL	$3.5 - $5.65 $17,500 - $28,250	-5,000 Reduced 83.33%	1,000 $1,000
Q3 2017 Oct 17, 2017	BUY	$4.5 - $5.65 $27,000 - $33,900	6,000	6,000 $3,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.